Neuronetics Inc (STIM)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Neuronetics Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 2 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 2.00 $ — 23% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 116.5% above the current price.
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Next Reporting Date
- Expected Earnings per Share
- -0.11 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.18 | – | 23 | 10.70 | -56.30 | -9 | -9 |
| 2025: Q1 | -0.18 | – | 32 | 83.60 | -39.60 | -17 | -17 |
| 2025: Q2 | -0.15 | – | 38 | 131.70 | -26.60 | -4 | -4 |
| 2025: Q3 | -0.13 | – | 37 | 101.30 | -24.30 | -1 | -1 |
| 2025: Q4 | -0.10 | – | 42 | 85.70 | -17.10 | 1 | 1 |
| 2026: Q1 | -0.16 | – | 35 | 7.80 | -31.30 | -9 | -10 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
Neuronetics, Inc. bietet in der Praxis durchgeführte Behandlungen für Patienten mit Neurohealth-Erkrankungen in den USA und international an.
| Employees | 658 |
|---|---|
| Headquarters | Malvern, PA |
| Website | neurostar.com/neuronetics |
| IPO Date | 28. Jun 2018 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Daniel L. Reuvers | CEO, President & Director | 1963 |
| W. Andrew Macan J.D. | EVP, Chief Legal Officer & Corporate Secretary | 1973 |
| Francis X. Brown III | Interim Principal Financial & Accounting Officer | – |
| Jeffrey S. Jones | Senior VP & Chief of Operations | 1956 |
| Cory S. Anderson | SVP & Chief Technology Officer | 1977 |
| Lisa Metzner-Rosas | Senior VP & Chief Marketing Officer | – |
| Robert Greene | Senior Vice President of Sales | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 23. Jul 2026 | Naor Nir | EVP, CFO & Treasurer | Other | 500,000 | 0.00 | – |
| 14. Jul 2026 | Chernett Jorey | 10% Owner | Buy | 35,000 | 1.78 | 62,300 |
| 20. Apr 2026 | Jorey Chernett | Major Shareholder | Buy | 100,000 | 1.58 | 158,000 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.